Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00564
|
|||||
| Drug Name |
Pyrilamide
|
|||||
| Synonyms |
2-((2-(Dimethylamino)ethyl)-(p-methoxybenzyl)amino)pyridine; 2-((p-Methoxybenzyl)(2-(dimethylamino)ethyl)amino)pyridine; 2-[(p-Methoxybenzyl)[2-(dimethylamino)ethyl]amino]pyridine; 2-[[2-(Dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine; 2-[[2-(Dimethylamino)ethyl]-(p-methoxybenzyl)amino]pyridine; 2-dimethylaminoethyl-p-anisyl-(2-pyridyl)amine; Afko-Hist; Anhistabs; Anhistol; Antalergan; Antallergan; Antamine; Anthisan; Copsamine; Coradon; Dipane; Dorantamin; Harvamine; Histacap; Histalon; Histapyran; Histasan; Isamin; Kriptin; Maranhist; Mepiramina; Mepiramina [INN-Spanish]; Mepiramine; Mepyramin; Mepyramin [German]; Mepyramine (INN); Mepyramine [INN:BAN]; Mepyraminum; Mepyraminum [INN-Latin]; Mepyren; N',N'-Dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)ethylenediamine; N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine; N,N-dimethyl-N'-{[4-(methyloxy)phenyl]methyl}-N'-pyridin-2-ylethane-1,2-diamine; N-((4-Methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N-(4-methoxybenzyl)-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha.-pyridyl)ethylenediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-(pyridylethylene)diamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridyl-1,2-ethanediamine; N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine; N-(para-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine; N-Dimethylamino-aethyl-N-p-methoxy-benzyl-.alpha.-amino-pyridin-maleat; N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine; N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyridin-2-amine; N-p-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine; N-para-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine; Neo-Bridal; Neoantergan; Neobridal; Nyscaps; P-Methoxy-benzyl-.alpha.-pyridyl-dimethyl-aethylendiamin; P-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin; P-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin [German]; PYRA; Paraminyl; Parmal; Pyramal; Pyranisamine; Pyrilamide; Pyrilamine; Pyrilamine salt with fine resin; R.d. 2786; RP 2786; Stamine; Stangen; Statomin; Thylogen; Wait's green mountain antihistamine; [3H]mepyramine; [3H]pyrilamine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Allergy [ICD11: 4A8Z] | Approved | [1] | |||
| Therapeutic Class |
Antiasthmatic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H23N3O
|
|||||
| Canonical SMILES |
CN(C)CCN(CC1=CC=C(C=C1)OC)C2=CC=CC=N2
|
|||||
| InChI |
InChI=1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3/i5T
|
|||||
| InChIKey |
YECBIJXISLIIDS-XHHURNKPSA-N
|
|||||
| CAS Number |
CAS 91-84-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 287.39 | Topological Polar Surface Area | 28.6 | ||
| Heavy Atom Count | 21 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.3
|
|||||
| PubChem CID | ||||||
| PubChem SID | ||||||
| ChEBI ID |
ChEBI:6762
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OCTN2 | Transporter Info | Organic cation/carnitine transporter 2 | Substrate | [2] | |
| References | ||||||
| 1 | Pyrilamide was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Genetic deficiency of carnitine/organic cation transporter 2 (slc22a5) is associated with altered tissue distribution of its substrate pyrilamine in mice. Biopharm Drug Dispos. 2009 Dec;30(9):495-507. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.